Ly6Chi Monocytes Delivering pH‐Sensitive Micelle Loading Paclitaxel Improve Targeting Therapy of Metastatic Breast Cancer
Authors:
- 11 May 2017
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 27 (26)
Abstract
Many immune cells are capable of homing to sites of disease and eradicating infections and abnormal cells. However, their efficacy is usually down‐regulated in tumor microenvironments and it is difficult to boost. It is presumed that the anticancer activity of immune cells can be improved by integrating an additional therapeutic modality such as chemotherapy into the cells. Here, Ly6Chi monocytes armed with the paclitaxel (PTX)‐loading pH‐sensitive micelle (PM), termed as PM@MC, are prepared. The PM internalization does not significantly affect the properties of the host Ly6Chi monocytes. In the 4T1 metastatic breast cancer mice model, PM@MCs home to both primary tumor and the lung metastasis foci. PM@MC exhibit 15‐fold higher intratumor PTX accumulation than the commercial PTX injection, and achieve a tumor inhibiting rate of 96.8% and a lung metastasis suppression rate of 99.2%. No significant change is recorded in histology of major organs and in hematological and biochemical parameters after PM@MC treatment. The pH‐sensitive micelle/Ly6Chi monocyte drug delivery device thus has the application potential in the targeting therapy of breast cancer with metastasis.Keywords
Funding Information
- National Natural Science Foundation of China (81630052, 81690265, 81521005)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2015226)
This publication has 46 references indexed in Scilit:
- LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic markerNature Medicine, 2012
- Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer modelActa Pharmacologica Sinica, 2012
- Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin NanoparticlesACS Nano, 2011
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Investigation of Correlation Among Safety Biomarkers in Serum, Histopathological Examination, and ToxicogenomicsInternational Journal of Toxicology, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) MonocytesCancer Research, 2010
- The macrophage marches on its phagosome: dynamic assays of phagosome functionNature Reviews Immunology, 2009
- Nanostructured Biomaterials for RegenerationAdvanced Functional Materials, 2008